POINT MUTATION AT CODON-12 OF THE KI-RAS GENE IN A PRIMARY BREAST-CARCINOMA AND THE MDA-MB-134 HUMAN MAMMARY-CARCINOMA CELL-LINE

被引:14
|
作者
PROSPERI, MT
DUPRE, G
LIDEREAU, R
GOUBIN, G
机构
[1] INST CURIE,ONCOGENESE MOLEC LAB,26 RUE ULM,F-75005 PARIS,FRANCE
[2] CHU HENRI MONDOR,ONCOL FONDAMENTALE & CLIN LAB,F-94000 CRETEIL,FRANCE
[3] CTR RENE HUGUENIN,F-92210 ST CLOUD,FRANCE
关键词
breast cancer; Ki-ras oncogene; polymerase chain reaction; transfection assay;
D O I
10.1016/0304-3835(90)90053-Z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We found an activated Kirsten (Ki)-ras gene in the MDA-MB-134 breast carcinoma cell line by transfection of NIH3T3 cells. Oligonucleotide hybridization demonstrated that this cell line carries a single G to C point mutation at position 12 leading to a glycine-arginine substitution. However, only a fraction of the cell population seems to contain this Ki-ras mutation. Since mutations can occur in cell lines during in vitro culture, we searched in breast carcinoma samples for the presence of single mutations at codon 12, but also for the presence of the double mutation previously found in the H-466B breast carcinoma cell line. Using polymerase chain reaction (PCR), we detected one primary tumour carrying a single mutation at codon 12. No double mutation was found in any of the tumours. These results show that Ki-ras gene mutation could be involved in breast carcinogenesis, albeit at a low frequency. © 1990.
引用
收藏
页码:169 / 174
页数:6
相关论文
共 35 条
  • [1] THE HUMAN C-KIRSTEN RAS GENE IS ACTIVATED BY A NOVEL MUTATION IN CODON-13 IN THE BREAST-CARCINOMA CELL-LINE MDA-MB231
    KOZMA, SC
    BOGAARD, ME
    BUSER, K
    SAURER, SM
    BOS, JL
    GRONER, B
    HYNES, NE
    NUCLEIC ACIDS RESEARCH, 1987, 15 (15) : 5963 - 5971
  • [2] Structural heterogeneity of hsr(11) in the MDA-MB-134 mammary carcinoma cell line
    Lemieux, N
    Apiou, F
    Vogt, N
    Malfoy, B
    Dutrillaux, B
    CANCER GENETICS AND CYTOGENETICS, 1996, 90 (01) : 75 - 79
  • [3] Point mutations in the KI-RAS gene codon 12 and 13 are infrequent in oral squamous cell carcinoma
    Rathcke, IO
    Goeroegh, T
    Lippert, BM
    Hoffmann, M
    Werner, JA
    ORAL ONCOLOGY, VOL V, 1997, : 393 - 396
  • [4] STRUCTURE OF THE KI-RAS GENE OF THE HUMAN-LUNG CARCINOMA CELL-LINE CALU-1
    SHIMIZU, K
    BIRNBAUM, D
    RULEY, MA
    FASANO, O
    SUARD, Y
    EDLUND, L
    TAPAROWSKY, E
    GOLDFARB, M
    WIGLER, M
    NATURE, 1983, 304 (5926) : 497 - 500
  • [5] GLUCOCORTICOID MODULATION OF PLASMINOGEN ACTIVATORS AND OF ONE OF THEIR INHIBITORS IN THE HUMAN MAMMARY-CARCINOMA CELL-LINE MDA-MB-231
    BUSSO, N
    BELIN, D
    FAILLYCREPIN, C
    VASSALLI, JD
    CANCER RESEARCH, 1987, 47 (02) : 364 - 370
  • [6] MUTATIONS OF KI-RAS ONCOGENE CODON-12 IN BETEL QUID CHEWING-RELATED HUMAN ORAL SQUAMOUS-CELL CARCINOMA IN TAIWAN
    KUO, MYP
    JENG, JH
    CHIANG, CP
    HAHN, LJ
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 1994, 23 (02) : 70 - 74
  • [7] ESTABLISHMENT AND CHARACTERIZATION OF A NEW CELL-LINE FROM PRIMARY HUMAN BREAST-CARCINOMA
    AMADORI, D
    BERTONI, L
    FLAMIGNI, A
    SAVINI, S
    DEGIOVANNI, C
    CASANOVA, S
    DEPAOLA, F
    AMADORI, A
    GIULOTTO, E
    ZOLI, W
    BREAST CANCER RESEARCH AND TREATMENT, 1993, 28 (03) : 251 - 260
  • [8] THE POINT MUTATION OF C-KI-RAS AT CODON-12 IN CARCINOMA OF THE PANCREATIC HEAD REGION AND IN INTRADUCTAL MUCIN-HYPERSECRETING NEOPLASM OF THE PANCREAS
    SATOH, K
    SAWAI, T
    SHIMOSEGAWA, T
    KOIZUMI, M
    YAMAZAKI, T
    MOCHIZUKI, F
    TOYOTA, T
    INTERNATIONAL JOURNAL OF PANCREATOLOGY, 1993, 14 (02) : 135 - 143
  • [10] ISOLATION AND PARTIAL CHARACTERIZATION OF SURFACE COMPONENTS OF CELL-LINE MDA-MB-231 DERIVED FROM A HUMAN METASTATIC BREAST-CARCINOMA
    WALKERNASIR, E
    CODINGTON, JF
    JAHNKE, MR
    FULLER, TC
    JEANLOZ, RW
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1982, 69 (02): : 371 - 380